title: Fluorescent transgenic zebrafish Tg(nkx2.2a:mEGFP) provides a highly sensitive monitoring tool for neurotoxins.
abstract: Previously a standard toxicological test termed as DarT (Danio rerio Teratogenic assay) using wild type zebrafish embryos has been established and it is widely applied in toxicological and chemical screenings. As an increasing number of fluorescent transgenic zebrafish lines with specific fluorescent protein expression specifically expressed in different organs and tissues, we envision that the fluorescent markers may provide more sensitive endpoints for monitoring chemical induced phenotypical changes. Here we employed Tg(nkx2.2a:mEGFP) transgenic zebrafish which have GFP expression in the central nervous system to investigate its potential for screening neurotoxic chemicals. Five potential neurotoxins (acetaminophen, atenolol, atrazine, ethanol and lindane) and one neuroprotectant (mefenamic acid) were tested. We found that the GFP-labeled ventral axons from trunk motoneurons, which were easily observed in live fry and measured for quantification, were a highly sensitive to all of the five neurotoxins and the length of axons was significantly reduced in fry which looked normal based on DarT endpoints at low concentrations of neurotoxins. Compared to the most sensitive endpoints of DarT, ventral axon marker could improve the detection limit of these neurotoxins by about 10 fold. In contrast, there was no improvement for detection of the mefenamic acid compared to all DarT endpoints. Thus, ventral axon lengths provide a convenient and measureable marker specifically for neurotoxins. Our study may open a new avenue to use other fluorescent transgenic zebrafish embryos/fry to develop sensitive and specific toxicological tests for different categories of chemicals.
authors: Department of Biological Sciences, National University of Singapore, Singapore, Singapore.
authors: Xiaoyan
authors: X
authors: Zhang
authors: Zhiyuan
authors: Z
authors: Gong
mesh_terms: D000082:Acetaminophen; D000818:Animals; D030801:Animals, Genetically Modified; D001262:Atenolol; D001280:Atrazine; D001369:Axons / Q000187:drug effects; D002490:Central Nervous System / Q000378:metabolism*; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D000431:Ethanol; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism*; D001556:Hexachlorocyclohexane; D008528:Mefenamic Acid; D009046:Motor Neurons / Q000187:drug effects*; D009498:Neurotoxins / Q000633:toxicity*; D012680:Sensitivity and Specificity; D018675:Toxicity Tests / Q000379:methods*; D015027:Zebrafish
chemical_list: D009498:Neurotoxins; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D000082:Acetaminophen; D008528:Mefenamic Acid; D000431:Ethanol; D001262:Atenolol; D001556:Hexachlorocyclohexane; D001280:Atrazine
references: Toxicology. 2010 Sep 10;275(1-3):36-49
references: 20566340
references: Toxicology. 2011 Jan 11;279(1-3):19-26
references: 20624442
references: Neurobehav Toxicol Teratol. 1986 Jan-Feb;8(1):11-5
references: 2422564
references: Drug Chem Toxicol. 1998 Feb;21(1):35-46
references: 9530529
references: Neurotoxicol Teratol. 2010 Jul-Aug;32(4):472-80
references: 20211721
references: Zebrafish. 2011 Dec;8(4):181-2
references: 22181660
references: J Appl Toxicol. 2013 Jun;33(6):410-7
references: 22045596
references: Nat Methods. 2009 Dec;6(12):911-6
references: 19898487
references: J Appl Toxicol. 2009 Oct;29(7):597-602
references: 19533668
references: Behav Brain Res. 2007 Aug 22;182(1):109-18
references: 17586062
references: Crit Rev Toxicol. 2010 Aug;40(7):620-32
references: 20569195
references: Genetica. 2001;111(1-3):213-25
references: 11841167
references: Br J Pharmacol. 2001 Jan;132(1):205-12
references: 11156579
references: ALTEX. 2002;19 Suppl 1:38-48
references: 12096329
references: Birth Defects Res A Clin Mol Teratol. 2006 Jul;76(7):553-67
references: 16933308
references: Dev Dyn. 2009 Mar;238(3):656-63
references: 19235725
references: Alcohol Clin Exp Res. 2000 Apr;24(4):512-8
references: 10798588
references: Expert Opin Drug Metab Toxicol. 2011 May;7(5):579-89
references: 21345150
references: Dev Biol. 2007 Apr 15;304(2):875-90
references: 17335795
references: Physiol Plant. 2003 May;118(1):47-56
references: 12702013
references: PLoS One. 2010 Dec 10;5(12):e15360
references: 21170329
references: Toxicol Appl Pharmacol. 2010 Jun 1;245(2):191-202
references: 20211194
references: Nat Neurosci. 2008 Feb;11(2):143-51
references: 18176560
references: Toxicol Sci. 2005 Jul;86(1):6-19
references: 15703261
references: Neurochem Int. 2009 Dec;55(7):683-8
references: 19563851
references: Nat Rev Genet. 2007 May;8(5):353-67
references: 17440532
references: Free Radic Biol Med. 2008 Dec 1;45(11):1542-50
references: 18845238
references: Drug Metab Rev. 2012 Feb;44(1):127-40
references: 22242931
references: Genome Biol. 2007;8(10):R227
references: 17961207
references: Neurotoxicol Teratol. 2010 Jan-Feb;32(1):91-8
references: 19460430
references: FASEB J. 2008 Feb;22(2):383-90
references: 17884974
references: Comp Biochem Physiol C Toxicol Pharmacol. 2010 May;151(4):480-6
references: 20170747
references: Toxicol Appl Pharmacol. 2008 Aug 15;231(1):10-6
references: 18486174
references: J Neurobiol. 2000 Nov 5;45(2):95-104
references: 11018771
references: Reprod Toxicol. 2009 Sep;28(2):245-53
references: 19406227
references: Drug Discov Today. 2008 May;13(9-10):394-401
references: 18468556
references: PLoS Genet. 2008 Jul 11;4(7):e1000121
references: 18618001
references: BMC Dev Biol. 2010 Oct 18;10:105
references: 20950494
references: Neurotoxicol Teratol. 2011 Nov-Dec;33(6):618-23
references: 21903162
references: Dev Biol. 2005 Oct 1;286(1):114-35
references: 16125164
references: Nat Neurosci. 2006 Dec;9(12):1506-11
references: 17099706
references: Toxicol Sci. 2011 May;121(1):146-59
references: 21346248
references: Dev Biol. 2003 Apr 1;256(1):1-17
references: 12654288
references: Eur J Pharmacol. 2005 Sep 5;519(1-2):146-53
references: 16084509